Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Standard Application Assessment Makes A Comeback
Sep 28 2023
•
By
Derrick Gingery
Priority review voucher user fees will decrease nearly 14% in FY 2024. • Source: Shutterstock
More from User Fees
More from Pathways & Standards